FDA Perspective: Conducting Clinical Trials in Pediatric Patients with Chronic Kidney Disease

Time: 4:30 pm
day: Day One


  • Evaluating regulatory perspectives on importance of conducting pediatric trials in rare and chronic kidney diseases
  • Why do we need to conduct trials in children and what resources are already available?
  • Pioneering a pathway to robust trials in children and reduce off-label drug use